Markers previously reported to be associated with metastasis aggressiveness in this patient cohort (MetA, MetB, and MetC subtypes; tumour cell proliferation index; and PSA and AR IR scores) were compared between the group with a myeloma-like pattern and the group with a non–myeloma-like pattern (Table 5). Here, AR is linked to neoplasm.